February 23, 2026 01:00 ET | Source: argenx SE February 23, 2026Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX),…
Pivotal ADAPT SERON results and interim ADAPT Jr data showcase VYVGART’s potential to treat broad set of myasthenia gravis patientsReal-world…